This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Helen of Troy Q2 Earnings Coming Up: Here's What You Should Know
by Zacks Equity Research
HELE's Q2 performance is likely to reflect the impacts of weak consumer spending amid inflationary pressures.
Evaluating PepsiCo Before Q3 Earnings: Buy the Stock Now or Hold Off?
by Rajani Lohia
Continued soft trends in North America, including headwinds in the QFNA segment, are expected to mar PEP's Q3 results. Its growth initiatives appear promising.
Is PepsiCo Stock a Buy, Sell or Hold at a 19.8X P/E Multiple?
by Rajani Lohia
While PEP's North America business remains troubled, its strategies and execution indicate long-term growth potential.
STZ Q2 Earnings: Will Soft Wine & Spirits Trends to Mar Results?
by Zacks Equity Research
Soft demand trends and category headwinds in the wine & spirits business are expected to affect Constellation Brands in Q2, offset by a resilient beer segment.
Zacks Industry Outlook Highlights Coca-Cola, PepsiCo, Keurig Dr Pepper, Monster Beverage and Vita Coco
by Zacks Equity Research
Coca-Cola, PepsiCo, Keurig Dr Pepper, Monster Beverage and Vita Coco are part of the Zacks Industry Outlook article.
Top 5 Soft Drink Stocks Ready to Weather Industry Challenges
by Rajani Lohia
Beverages - Soft Drinks companies such as KO, PEP, KDP, MNST, and COCO remain strong, driven by robust consumer demand, innovation initiatives, category expansions, and increased digital investments, despite ongoing inflationary pressures.
Monster Beverage's Expansion Strategy Aids: Apt to Hold the Stock?
by Zacks Equity Research
MNST sees strength in its energy drinks category. Its expansion strategy also bodes well.
Monster Beverage's Investment Potential: Why MNST Could Surprise You
by Zacks Equity Research
MNST suffers from reduced traffic in convenience stores and a retail shift toward mass and dollar channels. Does the stock hold upward prospects?
Is CELH Stock's 31.5X PE Still Worth It? Time to Buy, Sell or Hold?
by Vrishali Bagree
Despite CELH's strategic focus, slowing revenue growth, shrinking market share, dependence on a single distributor and high input costs raise concerns.
Why Is Monster Beverage (MNST) Up 7.1% Since Last Earnings Report?
by Zacks Equity Research
Monster Beverage (MNST) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Celsius Stock Crash: Is This a Buying Opportunity?
by Ethan Feller
Celsius stock was rocketing higher until the last few months... is it worth investing at current levels?
PEP Stock Moves Mere 5% in Six Months: Time to Sell or Stay Patient?
by Rajani Lohia
PepsiCo stays on the radar as slowing North America sales cast a shadow on its near-term growth prospects. Investors look skeptical about its sparse growth.
KO Stock Reaches 52-Week High: Should You Buy, Hold, or Sell?
by Rajani Lohia
After the Coca-Cola stock hits a 52-week high, we assess whether the current level warrants an opportunity to accumulate shares, hold positions or book profits.
Celsius Holdings (CELH) Trading Near 52-Week Low: How to Play Ahead?
by Vrishali Bagree
Celsius Holdings (CELH) is troubled by intensified competition, over-reliance on key partnerships and broader economic uncertainties, while innovation and expansion efforts are a breather.
Monster Beverage (MNST) International Revenue Performance Explored
by Zacks Equity Research
Examine the evolution of Monster Beverage's (MNST) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Here's What Key Metrics Tell Us About Monster Beverage (MNST) Q2 Earnings
by Zacks Equity Research
The headline numbers for Monster Beverage (MNST) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Monster Beverage (MNST) Stock Down on Q2 Earnings & Sales Miss
by Zacks Equity Research
Monster Beverage (MNST) posts soft second-quarter 2024 results. Its Monster Energy Drinks segment's sales rise 3.3% year over year.
Monster Beverage (MNST) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Monster Beverage (MNST) delivered earnings and revenue surprises of -8.89% and 6.04%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Investors Await Initial Jobless Claims Report
by Zacks Equity Research
Investors Await Initial Jobless Claims Report
Pre-Markets in the Green as Rebound Continues
by Zacks Equity Research
U.S. stock futures are trying to hold on to yesterday???s rebound after three straight sessions of bloodbath.
Monster Beverage's (MNST) Q2 Earnings Coming Up: Things to Note
by Zacks Equity Research
Monster Beverage's (MNST) second-quarter 2024 results are likely to reflect gains from strength in its energy drinks category and product launches.
Unveiling Monster Beverage (MNST) Q2 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Monster Beverage (MNST) for the quarter ended June 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
PepsiCo (PEP) Stirs Mix Reactions Post Q2 Earnings: Hold or Fold?
by Rajani Lohia
PepsiCo's (PEP) second-quarter 2024 results present a complex picture of its current standing, notably impacted by product recalls in its North America operations.
Monster Beverage (MNST) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Monster Beverage (MNST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Investing in Coca-Cola (KO) Before Q2 Earnings: Smart Move?
by Rajani Lohia
A robust brand portfolio, strategic investments and growth across segments are likely to have aided Coca-Cola's (KO) Q2 sales and volumes. Inflationary pressures and currency woes may dampen results.